findmyKOL

Henry Fraimow, MD

Basic profile

Cooper University Hospital

ORCIDNPI
RegionCamden, NJ · NortheastSpecialtyInfectious DiseaseFocusInfectious Disease
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Henry Fraimow is an Infectious Disease physician affiliated with Cooper University Hospital. OpenAlex indexes 74 publications with 1,595 citations (h-index 22).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
74publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,595citations

Total citations across indexed works.

22h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

3 Cooper Plz
Suite 513 (infectious Disease)
Camden, NJ 081031438

Telephone

856-963-3715

Registry record last updated 24 Sept 2010.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    76%
    Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor24.5%
    Descovy40%Triumeq34%Abacavir-Lamivudine26%
    Part D<11 patients
    Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor21.3%
    Tivicay44%Juluca41%Isentress15%
    Part D<11 patients

    + 7 more classes in this area

  • Cardiovascular

    10.5%
    ACE inhibitor4.3%
    Lisinopril100%
    Part D<11 patients
    Statin3.2%
    Atorvastatin Calcium100%
    Part D<11 patients

    + 1 more class in this area

  • Nervous system

    8.1%
    Benzodiazepine4.6%
    Clonazepam100%
    Part D<11 patients
    Opioid Agonist3.5%
    Oxycodone-Acetaminophen100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”